Zhigang Hu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Cell death and differentiation

Oncogene

Cell death & disease

Biomedicines

Nanjing Normal University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nanjing Normal University Jan 21 2014

China

ASSOCIATE PROFESSOR :: SCHOOL OF LIFE SCIENCE

Stanford University School of Medicine Feb 08 2010 - Nov 09 2013

United States

POSTDOCTORAL

Publications

Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Meina Wang, Kaili Long, Enjie Li, Lulu Li, Binghua Li, Shusheng Ci, Lingfeng He, Feiyan Pan, Zhigang Hu, Zhigang Guo
Correction: DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation. Oncogene (2023)
Wenwen Chen, Zhigang Hu, Zhigang Guo
Targeting CD24 in Cancer Immunotherapy. Biomedicines 11 (12) (2023)
Wenwen Chen, Zhigang Hu, Zhigang Guo
Targeting CD24 in Cancer Immunotherapy. Biomedicines 11 (12) (2023)
Munan Shi, Jiajia Hou, Weichu Liang, Qianwen Li, Shan Shao, Shusheng Ci, Chuanjun Shu, Xingqi Zhao, Shanmeizi Zhao, Miaoling Huang, Congye Wu, Zhigang Hu, Lingfeng He, Zhigang Guo, Fei-Yan Pan
GAPDH facilitates homologous recombination repair by stabilizing RAD51 in an HDAC1-dependent manner. EMBO reports (2023)
Ying Ma, Yang Yang, Jingyu Xin, Lingfeng He, Zhigang Hu, Tao Gao, Fei-Yan Pan, Zhigang Guo
RNA G-Quadruplex within the 5'-UTR of FEN1 Regulates mRNA Stability under Oxidative Stress. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Ying Ma, Yang Yang, Jingyu Xin, Lingfeng He, Zhigang Hu, Tao Gao, Fei-Yan Pan, Zhigang Guo
RNA G-Quadruplex within the 5'-UTR of FEN1 Regulates mRNA Stability under Oxidative Stress. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Enjie Li, Mingyue Xia, Yu Du, Kaili Long, Feng Ji, Fei-Yan Pan, Lingfeng He, Zhigang Hu, Zhigang Guo
METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis. eLife 11 (2022)
Lili Gu, Yuling Sun, Ting Wu, Ge Chen, Xiaojun Tang, Lianfeng Zhao, Lingfeng He, Zhigang Hu, Lingyun Sun, Fei-Yan Pan, Zhimin Yin, Zhigang Guo
A novel mechanism for macrophage pyroptosis in rheumatoid arthritis induced by Pol β deficiency. Cell death & disease 13 (7) (2022)
Jiannan Chen, Jianhua Hu, Lili Gu, Feng Ji, Fan Zhang, Miaomiao Zhang, Jun Li, Zhengliang Chen, Longwei Jiang, Yan Zhang, Ruifang Shi, Lihua Ma, Shaochang Jia, Ying Zhang, Qi Zhang, Junqing Liang, Shunyu Yao, Zhigang Hu, Zhigang Guo
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer. Cancer immunology, immunotherapy : CII (2022)
Feng Ji, Fan Zhang, Miaomiao Zhang, Kaili Long, Mingyue Xia, Fei Lu, Enjie Li, Jiannan Chen, Jun Li, Zhengliang Chen, Li Jing, Shaochang Jia, Rong Yang, Zhigang Hu, Zhigang Guo
Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway. Journal of hematology & oncology 14 (1) (2021)
Kaili Long, Lili Gu, Lulu Li, Ziyu Zhang, Enjie Li, Yilan Zhang, Lingfeng He, Feiyan Pan, Zhigang Guo, Zhigang Hu
Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer. Cell death & disease 12 (6) (2021)
Meina Wang, Kaili Long, Enjie Li, Lulu Li, Binghua Li, Shusheng Ci, Lingfeng He, Feiyan Pan, Zhigang Hu, Zhigang Guo
DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation. Oncogene 39 (33) (2020)
Jing Zhang, Li Jing, Subee Tan, Er-Ming Zeng, Yingbo Lin, Lingfeng He, Zhigang Hu, Jianping Liu, Zhigang Guo
Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs. Cell death & disease 11 (7) (2020)
Xiao Lu, Rui Liu, Meina Wang, Alagamuthu Karthick Kumar, Feiyan Pan, Lingfeng He, Zhigang Hu, Zhigang Guo
MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer. Oncogene 39 (1) (2019)

Zhigang Hu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhigang Hu